Evidence mapPaperPMID 35443045Full record

ArticleThe oncologist2022

Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care.

Kelly E Irwin, Naomi Ko, Elizabeth P Walsh, Veronica Decker, Isabel Arrillaga-Romany, Scott R Plotkin, Jeffrey Franas, Emily Gorton, Beverly Moy

Open access · goldAbstract read
In one paragraph

Article in The oncologist, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Developing the multidisciplinary and multispecialty workforce and the systems needed to sustain high-quality care from diagnosis through long-term survivorship.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Kelly E IrwinMassachusetts General Hospital Cancer Center, Boston, MA, USA.
Naomi KoDepartment of Medical Oncology, Boston Medical Center, Boston, MA, USA.
Elizabeth P WalshMassachusetts General/North Shore Cancer Center, Danvers, MA, USA.
Veronica DeckerUniversity of Central Florida College of Nursing, Orlando, FL, USA.
Isabel Arrillaga-RomanyMassachusetts General Hospital Cancer Center, Boston, MA, USA.
Scott R PlotkinMassachusetts General Hospital Cancer Center, Boston, MA, USA.
Jeffrey FranasEliot Community Health Services, MA, USA.
Emily GortonMassachusetts General Hospital Cancer Center, Boston, MA, USA.
Beverly MoyMassachusetts General Hospital Cancer Center, Boston, MA, USA.ORCID 0000-0003-3472-1140
Massachusetts General Hospital · USHarvard University · USBoston Medical Center · USNorth Shore Community College · USUniversity of Central Florida · US

Funding

Tumor Imaging Metrics CoreP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · 1985 to 2025
$168.8M
NCI NIH HHS K08 CA230185NCI NIH HHS P30 CA006516
6 · The paper itself

Abstract

We define cancer equity as all people having as the same opportunity for cancer prevention, treatment, and survivorship care. However, marginalized populations continue to experience avoidable and unjust disparities in cancer care, access to clinical trials, and cancer survival. Racial and ethnic minorities, and individuals with low socioeconomic status, Medicaid insurance, limited health literacy, disabilities, and mental health disorders are more likely to experience delays to cancer diagnosis and less likely to receive guideline-concordant cancer care. These disparities are impacted by the social determinants of health including structural discrimination, racism, poverty, and inequities in access to healthcare and clinical trials. There is an urgent need to develop and adapt evidence-based interventions in collaboration with community partners that have potential to address the social determinants of health and build capacity for cancer care for underserved populations. We established the Virtual Equity Hub by developing a collaborative network connecting a comprehensive cancer center, academic safety net hospital, and community health centers and affiliates. The Virtual Equity Hub utilizes a virtual tumor board, an evidence-based approach that increases access to multi-specialty cancer care and oncology subspecialty expertise. We adapted the tumor board model by engaging person-centered teams of multi-disciplinary specialists across health systems, addressing the social determinants of health, and applying community-based research principles with a focus on populations with poor cancer survival. The virtual tumor board included monthly videoconferences, case discussion, sharing of expertise, and a focus on addressing barriers to care and trial participation. Specifically, we piloted virtual tumor boards for breast oncology, neuro-oncology, and individuals with cancer and serious mental illness. The Virtual Equity Hub demonstrated promise at building capacity for clinicians to care for patients with complex needs and addressing barriers to care. Research is needed to measure the impact, reach, and sustainability of virtual equity models for patients with cancer.

Indexed as

Delivery of Health CareNeoplasmsHumansMedical OncologyRacial GroupsUnited StatesVulnerable Populations

Identifiers

PMID35443045
PMCPMC9256021
OpenAlexW4220787552

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.